Australia markets closed

Neuren Pharmaceuticals Limited (NEU.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
11.18+0.38 (+3.52%)
At close: 04:10PM AEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
-
14,553
-
-
-
Gross profit
-
14,553
-
-
-
Operating expenses
Research development
19,191
12,712
9,516
7,763
9,858
Selling general and administrative
4,404
3,437
1,914
1,763
1,713
Total operating expenses
23,607
16,159
11,438
9,532
11,575
Operating income or loss
53,872
-1,606
-11,438
-9,532
-11,575
Total other income/expenses net
1,956
1,389
3,595
186
366
Income before tax
56,860
184
-7,794
-9,193
-10,816
Income tax expense
1,817
0
0
0
0
Income from continuing operations
55,043
184
-7,794
-9,193
-10,816
Net income
55,043
184
-7,794
-9,193
-10,816
Net income available to common shareholders
55,043
184
-7,794
-9,193
-10,816
Basic EPS
-
0.00
-0.07
-0.09
-0.11
Diluted EPS
-
0.00
-0.07
-0.09
-0.11
Basic average shares
-
125,966
117,770
107,057
100,168
Diluted average shares
-
125,966
117,770
107,057
100,168